Stocks Comparison
Bausch & Lomb vs Staar Surgical: revenue, profit, margins and growth compared
Bausch & Lomb brought in $5.1B of revenue in fiscal 2025, Staar Surgical $239.4M in fiscal 2025. Revenue changed by +6.5% at Bausch & Lomb and -23.7% at Staar Surgical on the year before, so Bausch & Lomb grew faster. Bausch & Lomb kept -7.1% of its revenue as net profit, Staar Surgical -33.6%. Free cash flow was -$66M at Bausch & Lomb and -$40.1M at Staar Surgical.
Side by side, latest fiscal year
| BLCO | STAA | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (January 2, 2026) |
| Revenue | $5.1B | $239.4M |
| Revenue growth | +6.5% | -23.7% |
| Net income | -$360M | -$80.4M |
| Net margin | -7.1% | -33.6% |
| Free cash flow | -$66M | -$40.1M |
| Free cash flow margin | -1.3% | -16.7% |
| Earnings per share (diluted) | -$1.02 | -$1.62 |
| Cash | $383M | $153.2M |
| Debt | $5B | n/a |
| Price to earnings | n/a | n/a |
| Market value | $6B | $1B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #61 of 523 · Health care | #239 of 523 · Health care |
Over the years
Questions about Bausch & Lomb and Staar Surgical
Which is bigger by revenue, Bausch & Lomb or Staar Surgical?
Bausch & Lomb is bigger by revenue: $5.1B in fiscal 2025, against $239.4M for Staar Surgical in fiscal 2025.
Which keeps more of its revenue as profit, Bausch & Lomb or Staar Surgical?
Bausch & Lomb had a net margin of -7.1% in fiscal 2025; Staar Surgical had -33.6% in fiscal 2025.
Which grew revenue faster, Bausch & Lomb or Staar Surgical?
In their latest fiscal years revenue changed by +6.5% at Bausch & Lomb and -23.7% at Staar Surgical.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.